Addendum

Enfortumab vedotin (urothelial cancer, first line treatment, combination with pembrolizumab) – Addendum to Project A24-98

Status
Status: Commission completed
Project no.
A25-22
Last updated

Report documents

  1. Addendum

    Enfortumab vedotin (urothelial cancer, first line treatment, combination with pembrolizumab) – Addendum to Project A24-98

    published on
    Document type
    PDF document, 5 MB, EN, not accessible
    DOI-Link
    https://doi.org/10.60584/A25-22_en

Dossier assessment

Indication:

First-line treatment of adult patients with unresectable or metastatic urothelial carcinoma who are eligible for platinum-containing chemotherapy

Result of dossier assessment:

unchanged after addendum:

  • Patients for whom cisplatin-based therapy is a suitable treatment option: hint of non-quantifiable added benefit
  • Patients for whom cisplatin-based therapy is not a suitable treatment option: hint of major added benefit

Additional information

Federal Joint Committee (G-BA)

2025-04-03 A G-BA decision was published.

G-BA documents on this decision

Project details

Project no.
A25-22
Commission
Commission awarded on 11.02.2025 by the Federal Joint Committee (GBA).
Report type
Addendum
Status
Commission completed
Department/Division
Drug Assessment
Topic
Cancer
Note

If the need for additional work on a project commissioned by the GBA arises during consultations, IQWiG submits an addendum. The subsequent decides on the extent of the added benefit concludes the early benefit assessment.

DOI

https://doi.org/10.60584/A25-22_en

Connected Projects

  1. Dossier assessment

    Enfortumab vedotin (urothelial cancer, first line) – Benefit assessment according to §35a Social Code Book V

    Project no.
    A24-98
    Last updated

    Status: Commission completed

  2. Dossier assessment

    Enfortumab vedotin (urothelial cancer, neoadjuvant + adjuvant) - Benefit assessment according to §35a Social Code Book V

    Project no.
    A26-94
    Last updated

    Status: Commission completed

Contact

Info Service (German)

Subscribe to daily updated information on projects, calls for tender, current vacancies and events as well as our press releases.

Register

Contact form

Questions about commissions, publications and press releases can be sent to us via this form.

Contact form